07 November 2018
Russian pharmaceutical and medical industry companies can be subsidized for partial reimbursement.
Such a support measure is implemented within the state program of the Russian Federation “Development of the pharmaceutical and medical industry” for 2013-2020.
The state aid measures are aimed at stimulating investment activities of Russian manufacturers to create, expand and revamp their facilities.
A list of projects subject to subsidies granting to pharmaceutical and medical industry companies is as follows:
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024